FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080594939> ?p ?o ?g. }

• W2080594939 endingPage "11778" @default.
• W2080594939 startingPage "11765" @default.
• W2080594939 abstract "Microtubule stabilizing agents (MSAs) comprise a class of drugs that bind to microtubule (MT) polymers and stabilize them against disassembly. Several of these agents are currently in clinical use as anticancer drugs, whereas others are in various stages of development. Nonetheless, there is insufficient knowledge about the molecular modes of their action. Recent studies from our laboratory utilizing hydrogen-deuterium exchange in combination with mass spectrometry (MS) provide new information on the conformational effects of Taxol and discodermolide on microtubules isolated from chicken erythrocytes (CET). We report here a comprehensive analysis of the effects of epothilone B, ixabepilone (IXEMPRATM), laulimalide, and peloruside A on CET conformation. The results of our comparative hydrogen-deuterium exchange MS studies indicate that all MSAs have significant conformational effects on the C-terminal H12 helix of α-tubulin, which is a likely molecular mechanism for the previously observed modulations of MT interactions with microtubule-associated and motor proteins. More importantly, the major mode of MT stabilization by MSAs is the tightening of the longitudinal interactions between two adjacent αβ-tubulin heterodimers at the interdimer interface. In contrast to previous observations reported with bovine brain tubulin, the lateral interactions between the adjacent protofilaments in CET are particularly strongly stabilized by peloruside A and laulimalide, drugs that bind outside the taxane site. This not only highlights the significance of tubulin isotype composition in modulating drug effects on MT conformation and stability but also provides a potential explanation for the synergy observed when combinations of taxane and alternative site binding drugs are used. Microtubule stabilizing agents (MSAs) comprise a class of drugs that bind to microtubule (MT) polymers and stabilize them against disassembly. Several of these agents are currently in clinical use as anticancer drugs, whereas others are in various stages of development. Nonetheless, there is insufficient knowledge about the molecular modes of their action. Recent studies from our laboratory utilizing hydrogen-deuterium exchange in combination with mass spectrometry (MS) provide new information on the conformational effects of Taxol and discodermolide on microtubules isolated from chicken erythrocytes (CET). We report here a comprehensive analysis of the effects of epothilone B, ixabepilone (IXEMPRATM), laulimalide, and peloruside A on CET conformation. The results of our comparative hydrogen-deuterium exchange MS studies indicate that all MSAs have significant conformational effects on the C-terminal H12 helix of α-tubulin, which is a likely molecular mechanism for the previously observed modulations of MT interactions with microtubule-associated and motor proteins. More importantly, the major mode of MT stabilization by MSAs is the tightening of the longitudinal interactions between two adjacent αβ-tubulin heterodimers at the interdimer interface. In contrast to previous observations reported with bovine brain tubulin, the lateral interactions between the adjacent protofilaments in CET are particularly strongly stabilized by peloruside A and laulimalide, drugs that bind outside the taxane site. This not only highlights the significance of tubulin isotype composition in modulating drug effects on MT conformation and stability but also provides a potential explanation for the synergy observed when combinations of taxane and alternative site binding drugs are used." @default.
• W2080594939 created "2016-06-24" @default.
• W2080594939 creator A5013606443 @default.
• W2080594939 creator A5021738971 @default.
• W2080594939 creator A5040379692 @default.
• W2080594939 creator A5043621005 @default.
• W2080594939 creator A5055337060 @default.
• W2080594939 creator A5056060354 @default.
• W2080594939 creator A5067520628 @default.
• W2080594939 creator A5075548551 @default.
• W2080594939 creator A5083740179 @default.
• W2080594939 date "2011-04-01" @default.
• W2080594939 modified "2023-10-04" @default.
• W2080594939 title "Hallmarks of Molecular Action of Microtubule Stabilizing Agents" @default.
• W2080594939 cites W1515396348 @default.
• W2080594939 cites W1532492916 @default.
• W2080594939 cites W1544176955 @default.
• W2080594939 cites W1558474974 @default.
• W2080594939 cites W1970169669 @default.
• W2080594939 cites W1970611771 @default.
• W2080594939 cites W1980561497 @default.
• W2080594939 cites W1982066209 @default.
• W2080594939 cites W1987933058 @default.
• W2080594939 cites W1988719871 @default.
• W2080594939 cites W1990326657 @default.
• W2080594939 cites W1994345832 @default.
• W2080594939 cites W1995567464 @default.
• W2080594939 cites W1996491270 @default.
• W2080594939 cites W2001135324 @default.
• W2080594939 cites W2004941701 @default.
• W2080594939 cites W2005731414 @default.
• W2080594939 cites W2011457585 @default.
• W2080594939 cites W2013944433 @default.
• W2080594939 cites W2028211819 @default.
• W2080594939 cites W2046655465 @default.
• W2080594939 cites W2048454522 @default.
• W2080594939 cites W2050285145 @default.
• W2080594939 cites W2055397209 @default.
• W2080594939 cites W2058997498 @default.
• W2080594939 cites W2061695900 @default.
• W2080594939 cites W2065177065 @default.
• W2080594939 cites W2068639744 @default.
• W2080594939 cites W2070116427 @default.
• W2080594939 cites W2070645384 @default.
• W2080594939 cites W2071817332 @default.
• W2080594939 cites W2078342982 @default.
• W2080594939 cites W2083295064 @default.
• W2080594939 cites W2088291116 @default.
• W2080594939 cites W2093609623 @default.
• W2080594939 cites W2098514397 @default.
• W2080594939 cites W2099243119 @default.
• W2080594939 cites W2107607807 @default.
• W2080594939 cites W2108929767 @default.
• W2080594939 cites W2117931147 @default.
• W2080594939 cites W2119651360 @default.
• W2080594939 cites W2130718258 @default.
• W2080594939 cites W2132741266 @default.
• W2080594939 cites W2137036197 @default.
• W2080594939 cites W2146641690 @default.
• W2080594939 cites W2151550848 @default.
• W2080594939 cites W2154094988 @default.
• W2080594939 cites W2159101935 @default.
• W2080594939 cites W2159293447 @default.
• W2080594939 cites W2161234125 @default.
• W2080594939 cites W2168703354 @default.
• W2080594939 doi "https://doi.org/10.1074/jbc.m110.162214" @default.
• W2080594939 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3064228" @default.
• W2080594939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21245138" @default.
• W2080594939 hasPublicationYear "2011" @default.
• W2080594939 type Work @default.
• W2080594939 sameAs 2080594939 @default.
• W2080594939 citedByCount "60" @default.
• W2080594939 countsByYear W20805949392012 @default.
• W2080594939 countsByYear W20805949392013 @default.
• W2080594939 countsByYear W20805949392014 @default.
• W2080594939 countsByYear W20805949392015 @default.
• W2080594939 countsByYear W20805949392016 @default.
• W2080594939 countsByYear W20805949392017 @default.
• W2080594939 countsByYear W20805949392018 @default.
• W2080594939 countsByYear W20805949392019 @default.
• W2080594939 countsByYear W20805949392020 @default.
• W2080594939 countsByYear W20805949392022 @default.
• W2080594939 countsByYear W20805949392023 @default.
• W2080594939 crossrefType "journal-article" @default.
• W2080594939 hasAuthorship W2080594939A5013606443 @default.
• W2080594939 hasAuthorship W2080594939A5021738971 @default.
• W2080594939 hasAuthorship W2080594939A5040379692 @default.
• W2080594939 hasAuthorship W2080594939A5043621005 @default.
• W2080594939 hasAuthorship W2080594939A5055337060 @default.
• W2080594939 hasAuthorship W2080594939A5056060354 @default.
• W2080594939 hasAuthorship W2080594939A5067520628 @default.
• W2080594939 hasAuthorship W2080594939A5075548551 @default.
• W2080594939 hasAuthorship W2080594939A5083740179 @default.
• W2080594939 hasBestOaLocation W20805949391 @default.
• W2080594939 hasConcept C121587506 @default.
• W2080594939 hasConcept C121608353 @default.
• W2080594939 hasConcept C12554922 @default.
• W2080594939 hasConcept C162356407 @default.

• next